Table 2.
All Study Participants | Severe Malaria Patients | |||||
---|---|---|---|---|---|---|
UM | SM | p | Non-hyperparasitaemia | Hyperparasitaemia | p | |
IL-12p40 (pg/mL), median (IQR) | 27.0 (10.0–98.8) | 95.1 (27.6–133.1) | 0.049 | 35.1 (12.5–103.9) | 121.9 (43.3–163.3) | 0.046 |
sample size | 56 | 25 | 14 | 11 | ||
IFN-γ (pg/mL), median (IQR) | 283.5 (118.5–473.5) | 387.0 (144.2–632.0) | 0.051 | 333.0 (136.7–580.2) | 486.0 (153.0–710.5) | 0.228 |
sample size | 106 | 75 | 42 | 33 |
Patients with P. falciparum infection were categorized as uncomplicated or severe malaria according to WHO criteria (WHO, 2000). Patients with severe malaria were further stratified as non- hyperparasitaemia (<250,000 parasites/µL) and hyperparasitaemia (≥250,000 parasites/µL). IL-12p40 and IFN-γ were measured in those subjects with adequate volumes of available plasma samples. Results are presented as median and interquartile range (IQR), with p≤0.05 considered statistically significant. Mann-Whitney U test was used to compare cytokine levels between the disease conditions.